FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packageng.gov.nphcda.immunization
Resource TypeAllergyIntolerance
IdAllergyIntolerance-allergyIntolerance-001.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: AllergyIntolerance allergyIntolerance-001

NG-Imm Allergy Dose Number: 165

NG-Imm Dose Series: Pentavalent Infant Series

clinicalStatus: Active

verificationStatus: Confirmed

type: Allergy

category: Medication, Biologic

criticality: High Risk

code: Adverse reaction to immunization

patient: Chinedu Emeka Okafor Male, DoB: 2020-05-15 ( NIN)

encounter: Encounter: extension = ; status = in-progress; class = PHC Center Level 2 (IMMZ.D.DE3 Facility Type CS#phc-center-l2)

onset: 2025-08-01 09:30:00+0100

recordedDate: 2025-08-01 10:00:00+0100

recorder: Practitioner Nkiru Okafor

lastOccurrence: 2025-08-01 12:00:00+0100

Reactions

-SubstanceManifestationDescriptionOnsetSeverity
*Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)Skin rashPatient developed rash and swelling within 30 minutes of immunization.2025-08-01 10:15:00+0100Moderate

Source1

{
  "resourceType": "AllergyIntolerance",
  "id": "allergyIntolerance-001",
  "meta": {
    "profile": [
      "https://nphcda.gov.ng/ig/StructureDefinition/allergy-intolerance-profile"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-number",
      "valueInteger": 165
    },
    {
      "url": "https://nphcda.gov.ng/ig/StructureDefinition/allergy-reference-dose-series",
      "valueString": "Pentavalent Infant Series"
    }
  ],
  "clinicalStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "code": "active",
        "display": "Active"
      }
    ]
  },
  "verificationStatus": {
    "coding": [
      {
        "system": "http://terminology.hl7.org/CodeSystem/allergyintolerance-verification",
        "code": "confirmed",
        "display": "Confirmed"
      }
    ]
  },
  "type": "allergy",
  "category": [
    "medication",
    "biologic"
  ],
  "criticality": "high",
  "code": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "293104008",
        "display": "Adverse reaction to immunization"
      }
    ]
  },
  "patient": {
    "reference": "Patient/patient-001"
  },
  "encounter": {
    "reference": "Encounter/encounter-001"
  },
  "onsetDateTime": "2025-08-01T09:30:00+01:00",
  "recordedDate": "2025-08-01T10:00:00+01:00",
  "recorder": {
    "reference": "Practitioner/practitioner-001"
  },
  "lastOccurrence": "2025-08-01T12:00:00+01:00",
  "reaction": [
    {
      "substance": {
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "333346007",
            "display": "Product containing precisely silver nitrate 200 milligram/1 milliliter conventional release cutaneous solution (clinical drug)"
          }
        ]
      },
      "manifestation": [
        {
          "coding": [
            {
              "system": "http://snomed.info/sct",
              "code": "271807003",
              "display": "Skin rash"
            }
          ]
        }
      ],
      "description": "Patient developed rash and swelling within 30 minutes of immunization.",
      "onset": "2025-08-01T10:15:00+01:00",
      "severity": "moderate"
    }
  ]
}